# Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)

> **NCT04163978** · PHASE2 · COMPLETED · sponsor: **Sanotize Research and Development corp.** · enrollment: 56 (actual)

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DRUG:** Nitric Oxide
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT04163978
- **Lead sponsor:** Sanotize Research and Development corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-27
- **Primary completion:** 2022-05-03
- **Final completion:** 2022-05-03
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04163978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04163978, "Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04163978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*